Peirong Ding

3.1k total citations
109 papers, 1.3k citations indexed

About

Peirong Ding is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Peirong Ding has authored 109 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Oncology, 50 papers in Surgery and 39 papers in Pathology and Forensic Medicine. Recurrent topics in Peirong Ding's work include Colorectal Cancer Surgical Treatments (45 papers), Colorectal and Anal Carcinomas (42 papers) and Genetic factors in colorectal cancer (39 papers). Peirong Ding is often cited by papers focused on Colorectal Cancer Surgical Treatments (45 papers), Colorectal and Anal Carcinomas (42 papers) and Genetic factors in colorectal cancer (39 papers). Peirong Ding collaborates with scholars based in China, United States and Macao. Peirong Ding's co-authors include Zhizhong Pan, Jinghua Tang, Yuanhong Gao, Xiaojun Wu, Jiang Wu, Li Li, Zhifan Zeng, Zhenhai Lu, Rui‐Hua Xu and Binyi Xiao and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Peirong Ding

97 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peirong Ding China 19 840 427 301 240 233 109 1.3k
Anwaar Saeed United States 18 964 1.1× 386 0.9× 186 0.6× 365 1.5× 198 0.8× 167 1.4k
Gordon Hutchins United Kingdom 14 1.0k 1.2× 271 0.6× 546 1.8× 310 1.3× 283 1.2× 26 1.4k
Jen‐Kou Lin Taiwan 21 672 0.8× 346 0.8× 275 0.9× 262 1.1× 142 0.6× 56 1.1k
Benjamin A. Weinberg United States 18 1.1k 1.3× 438 1.0× 329 1.1× 450 1.9× 315 1.4× 128 1.5k
Shaobo Mo China 21 506 0.6× 213 0.5× 132 0.4× 256 1.1× 198 0.8× 57 883
Diana L. Hanna United States 17 600 0.7× 164 0.4× 182 0.6× 250 1.0× 258 1.1× 75 1.0k
J. Tol Netherlands 11 878 1.0× 135 0.3× 234 0.8× 339 1.4× 258 1.1× 22 1.2k
Choong‐kun Lee South Korea 21 688 0.8× 351 0.8× 126 0.4× 490 2.0× 312 1.3× 100 1.6k
Itzhak Avital United States 22 590 0.7× 466 1.1× 132 0.4× 355 1.5× 453 1.9× 42 1.5k
Salvatore Tafuto Italy 24 1.0k 1.2× 162 0.4× 91 0.3× 267 1.1× 136 0.6× 99 1.5k

Countries citing papers authored by Peirong Ding

Since Specialization
Citations

This map shows the geographic impact of Peirong Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peirong Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peirong Ding more than expected).

Fields of papers citing papers by Peirong Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peirong Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peirong Ding. The network helps show where Peirong Ding may publish in the future.

Co-authorship network of co-authors of Peirong Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Peirong Ding. A scholar is included among the top collaborators of Peirong Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peirong Ding. Peirong Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Yi-Hang, Zhangjie Wang, Hengyu Zhao, et al.. (2025). RCMIX model based on pre-treatment MRI imaging predicts T-downstage in MRI-cT4 stage rectal cancer. Cancer Letters. 628. 217871–217871.
2.
Hou, Zhenlin, Weiwei Xiao, Qiaoqi Sui, et al.. (2025). Neoadjuvant chemoradiotherapy plus sintilimab in pMMR/MSS rectal cancer patients with PD-L1 TPS ≥ 1% or CPS ≥ 1: an open-label, prospective, phase II study. npj Precision Oncology. 9(1). 237–237. 1 indexed citations
3.
Tang, Jinghua, Jiang Wu, Yuan Li, et al.. (2024). The effects of oxaliplatin-based adjuvant chemotherapy in high-risk stage II colon cancer with mismatch repair-deficient: a retrospective study. BMC Cancer. 24(1). 164–164. 2 indexed citations
4.
Ding, Peirong, et al.. (2024). A growth factor-reduced culture system for colorectal cancer organoids. Cancer Letters. 588. 216737–216737. 10 indexed citations
5.
Li, Bin, Haina Yu, Rui Sun, et al.. (2024). Distinct clinical characteristics in stage III rectal cancer among different age groups and treatment outcomes after neoadjuvant chemoradiotherapy. Therapeutic Advances in Medical Oncology. 16. 12674170–12674170.
6.
Qin, Youwen, Xin Tong, Wei-Jian Mei, et al.. (2024). Consistent signatures in the human gut microbiome of old- and young-onset colorectal cancer. Nature Communications. 15(1). 3396–3396. 18 indexed citations
7.
Chu, Chengcai, J. G. Bian, Xiaohui Zhang, et al.. (2024). Modulation of the Differential Phase in Atom Gravity Gradiometer via a Bias Magnetic Field. IEEE Sensors Journal. 24(24). 40518–40523. 2 indexed citations
8.
Xiao, Binyi, Xuan Zhang, Dandan Li, et al.. (2023). Neoadjuvant Immunotherapy Leads to Major Response and Low Recurrence in Localized Mismatch Repair–Deficient Colorectal Cancer. Journal of the National Comprehensive Cancer Network. 21(1). 60–66.e5. 26 indexed citations
9.
Ding, Peirong. (2023). Application of Molecular Profiling in Colorectal Cancer Surgery. Clinics in Colon and Rectal Surgery. 36(6). 367–368. 1 indexed citations
10.
Li, Yuan, Bin Li, Rou Jiang, et al.. (2023). A novel screening method of DNA methylation biomarkers helps to improve the detection of colorectal cancer and precancerous lesions. Cancer Medicine. 12(21). 20626–20638. 9 indexed citations
11.
Dong, Xiaorong, Fan Tong, Yunyi Kong, et al.. (2023). EP13.07-09 The Role of Radiotherapy in Extensive-Stage Small Cell Lung Cancer after Durvalumab-Based Immunochemotherapy: A Retrospective Study. Journal of Thoracic Oncology. 18(11). S710–S710.
12.
Wang, Qiaoxuan, Binyi Xiao, Yong Cheng, et al.. (2022). Anti-PD-1-based immunotherapy as curative-intent treatment in dMMR/MSI-H rectal cancer: A multicentre cohort study. European Journal of Cancer. 174. 176–184. 19 indexed citations
13.
Zhang, Shu, Rong Zhang, Rongzhen Li, et al.. (2021). Beneficiaries of radical surgery among clinical complete responders to neoadjuvant chemoradiotherapy in rectal cancer. Cancer Science. 112(9). 3607–3615. 5 indexed citations
14.
Sui, Qiaoqi, Dingxin Liu, Jiang Wu, et al.. (2021). Dickkopf 1 impairs the tumor response to PD-1 blockade by inactivating CD8+ T cells in deficient mismatch repair colorectal cancer. Journal for ImmunoTherapy of Cancer. 9(3). e001498–e001498. 43 indexed citations
15.
Peng, Xiaolin, Wen‐Qiong Xue, Rong Zhang, et al.. (2021). A fecal-based test for the detection of advanced adenoma and colorectal cancer: a case-control and screening cohort study. BMC Medicine. 19(1). 250–250. 9 indexed citations
16.
Chang, Hui, Xin Yu, Kai Chen, et al.. (2018). Prognostic Value of the Cycle Number of Perioperative Chemotherapy in Locoregionally Advanced Rectal Cancer: a Propensity Score Matching Analysis. Journal of Cancer. 9(23). 4346–4354. 4 indexed citations
17.
Ding, Peirong, et al.. (2017). Status of Pre-hospital Delay and Influencing Factors of Delay Time in Patients with Colorectal Cancer. Zhongguo quanke yixue. 20(33). 4109–4114. 3 indexed citations
18.
19.
Liu, Guochen, Xu Zhang, Enzehua Xie, et al.. (2015). The Value of Restaging With Chest and Abdominal CT/MRI Scan After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. Medicine. 94(47). e2074–e2074. 7 indexed citations
20.
Gao, Yuanhong, X. Zhang, Xin An, et al.. (2014). Oxaliplatin and capecitabine concomitant with neoadjuvant radiotherapy and extended to the resting period in high risk locally advanced rectal cancer. Strahlentherapie und Onkologie. 190(2). 158–164. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anwaar Saeed Breakdown of academic impact, for papers by Gordon Hutchins Breakdown of academic impact, for papers by Jen‐Kou Lin Breakdown of academic impact, for papers by Benjamin A. Weinberg Breakdown of academic impact, for papers by Shaobo Mo Breakdown of academic impact, for papers by Diana L. Hanna Breakdown of academic impact, for papers by J. Tol Breakdown of academic impact, for papers by Choong‐kun Lee Breakdown of academic impact, for papers by Itzhak Avital Breakdown of academic impact, for papers by Salvatore Tafuto
Rankless by CCL
2026